HLS Therapeutics (HLS) News Today C$4.87 -0.01 (-0.20%) As of 02:56 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock HLS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period HLS Therapeutics Announces Reimbursement for Vascepa® under Nova Scotia's Provincial Drug PlanJuly 2, 2025 | finance.yahoo.comHLS Therapeutics Reports Annual Meeting ResultsJune 20, 2025 | finance.yahoo.comThe past five years for HLS Therapeutics (TSE:HLS) investors has not been profitableJune 20, 2025 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Trading 1.8% Higher - Here's What HappenedJune 17, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Sets New 52-Week High - What's Next?May 28, 2025 | marketbeat.comRaymond James Brokers Boost Earnings Estimates for TSE:HLSMay 17, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Trading Up 1.1% - Time to Buy?May 12, 2025 | marketbeat.comHLS Therapeutics First Quarter 2025 Earnings: EPS Misses ExpectationsMay 10, 2025 | finance.yahoo.comEarnings call transcript: HLS Therapeutics Q1 2025 results show mixed signalsMay 10, 2025 | uk.investing.comHLS Therapeutics Announces Q1 2025 Financial ResultsMay 10, 2025 | seekingalpha.comHLS Therapeutics (TSE:HLS) Trading Down 1.2% - Here's What HappenedApril 20, 2025 | marketbeat.comResearch Analysts Set Expectations for TSE:HLS Q1 EarningsMarch 28, 2025 | marketbeat.comStifel Nicolaus Issues Positive Forecast for HLS Therapeutics (TSE:HLS) Stock PriceMarch 27, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Stock Price Down 1.2% - Here's WhyMarch 14, 2025 | marketbeat.comHLS Therapeutics Inc (HLS) Receives a Hold from Stifel NicolausMarch 14, 2025 | markets.businessinsider.comHLS Therapeutics Appoints Christine Elliott to its Board of DirectorsMarch 13, 2025 | finance.yahoo.comHLS Therapeutics Gets Green Light for Share Buyback ProgramMarch 13, 2025 | marketwatch.comTop Canadian Pharmaceutical Stocks of 2025February 3, 2025 | fool.caHLS Therapeutics (TSE:HLS) Shares Down 1.5% - Here's WhyJanuary 29, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Stock Price Down 1.8% - What's Next?January 7, 2025 | marketbeat.comHLS Therapeutics (TSE:HLS) Shares Down 0.3% - What's Next?December 14, 2024 | marketbeat.comRaymond James Boosts HLS Therapeutics (TSE:HLS) Price Target to C$5.00November 22, 2024 | marketbeat.comStifel Canada Forecasts Weaker Earnings for HLS TherapeuticsNovember 15, 2024 | marketbeat.comOptimistic Buy Rating for HLS Therapeutics Despite Revenue ChallengesNovember 10, 2024 | markets.businessinsider.comHLS Therapeutics Third Quarter 2024 Earnings: Misses ExpectationsNovember 8, 2024 | finance.yahoo.comHLS Therapeutics Inc (HLTRF) Q3 2024 Earnings Call Highlights: Strategic Debt Reduction and ...November 8, 2024 | finance.yahoo.comHLS Therapeutics Inc (TSX:HLS) Q3 2024: Everything You Need To Know Ahead Of EarningsNovember 6, 2024 | finance.yahoo.comHLS Therapeutics (HLS) Set to Announce Earnings on ThursdayOctober 31, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Hits New 1-Year Low - What's Next?October 25, 2024 | marketbeat.comHLS Therapeutics Inc. (TSE:HLS) Shares Could Be 38% Below Their Intrinsic Value EstimateOctober 17, 2024 | finance.yahoo.comDantech Announces Participation as a Silver Sponsor at BioFuture 2024 in New York CityOctober 14, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Stock Price Down 4.3% - Time to Sell?October 10, 2024 | marketbeat.comHLS Therapeutics Inc (HLTRF) Q2 2024 Earnings Call Highlights: Strategic Growth Amid Revenue ...October 9, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Trading Down 0.6%September 18, 2024 | marketbeat.comHLS Therapeutics to Present at H.C. Wainwright's 26th Annual Global Investment ConferenceAugust 28, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Reaches New 12-Month Low at $3.00August 26, 2024 | marketbeat.comHLS Therapeutics Inc. (74D.F)August 23, 2024 | finance.yahoo.comHLS Therapeutics Inc. (TSE:HLS) to Post Q3 2024 Earnings of ($0.19) Per Share, Stifel Canada ForecastsAugust 15, 2024 | marketbeat.comHLS Therapeutics (TSE:HLS) Given New C$3.25 Price Target at Stifel NicolausAugust 13, 2024 | marketbeat.comFDA gives thumbs down to MDMA for now, demanding further researchAugust 13, 2024 | msn.comHLS Therapeutics Inc. to Post Q3 2024 Earnings of ($0.21) Per Share, Raymond James Forecasts (TSE:HLS)August 12, 2024 | marketbeat.comHLS Therapeutics Announces Q2 2024 Financial ResultsAugust 8, 2024 | finance.yahoo.comHLS Therapeutics (TSE:HLS) Hits New 12-Month Low at $3.02August 2, 2024 | marketbeat.comAmarin Corporation plc (NASDAQ:AMRN) Q2 2024 Earnings Call TranscriptAugust 1, 2024 | msn.comHLS Therapeutics (HLS) Scheduled to Post Quarterly Earnings on ThursdayAugust 1, 2024 | marketbeat.comAmarin Plc (AMRN) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | msn.comHLS Announces Reimbursement for Vascepa® under Alberta's Provincial Drug PlanJuly 29, 2024 | finance.yahoo.comFTSE 100 LIVE: European stocks slump after Wall Street suffers worst sell-off in over a yearJuly 25, 2024 | sg.finance.yahoo.comHLS Therapeutics to Host Q2 Fiscal 2024 Financial Results Conference CallJuly 25, 2024 | ca.finance.yahoo.comHLS Therapeutics (TSE:HLS) Reaches New 12-Month Low at $3.07July 24, 2024 | marketbeat.com Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address HLS Media Mentions By Week HLS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HLS News Sentiment▼0.000.57▲Average Medical News Sentiment HLS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HLS Articles This Week▼01▲HLS Articles Average Week Get HLS Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HLS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Tilray Brands News Today Aurora Cannabis News Today Canopy Growth News Today Organigram News Today Cipher Pharmaceuticals News Today Cardiol Therapeutics News Today BioSyent News Today SugarBud Craft Growers News Today Medexus Pharmaceuticals News Today Voyageur Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:HLS) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HLS Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HLS Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
